Behavioral and Pharmacological Treatment for Insomnia
Completed
National Institute of Mental Health (NIMH)
Phase 4
2001-12-01
This study will evaluate the long- and short-term effects of cognitive-behavior therapy
(CBT), alone and in combination with zolpidem (Ambien®), for chronic insomnia.
Behavioral and Pharmacological Treatment for Insomnia
Completed
Laval University
Phase 4
2001-12-01
This study will evaluate the long- and short-term effects of cognitive-behavior therapy
(CBT), alone and in combination with zolpidem (Ambien®), for chronic insomnia.
Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients
Completed
Jazz Pharmaceuticals
Phase 4
2003-11-01
To study the effect of Xyrem (9 g), Xyrem (9 g) plus modafinil 200 mg administered the
morning prior to Xyrem, positive control (zolpidem 10 mg), and placebo on the frequency and
outcome of events of sleep-disordered breathing in patients with obstructive sleep apnea
syndrome (OSAS).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
